Metraipolis › archive › dc_cbbb47b3bb39

Recurrence Patterns and Survival Outcomes in Clinical Stage IIB/IIC Melanoma: Can We Stratify Patients for Consideration of Neoadjuvant Immunotherapy? — Europe PMC PMID:40908447

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40908447
DOI
10.1245/s10434-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-10T03:15:56.387Z
SHA-256 of the archived text
62e97d95d84c47c3dfa9499f60c4b3a458cd726a1acc3880d9cda715ef205de9
Stable URL of this page
https://metraipolis.com/documento/dc_cbbb47b3bb39

How to cite

Recurrence Patterns and Survival Outcomes in Clinical Stage IIB/IIC Melanoma: Can We Stratify Patients for Consideration of Neoadjuvant Immunotherapy? — Europe PMC PMID:40908447 — Europe PMC (en), https://europepmc.org/article/MED/40908447 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cbbb47b3bb39 (Metraipolis archive dc_cbbb47b3bb39, sha256 62e97d95d84c47c3dfa9499f60c4b3a458cd726a1acc3880d9cda715ef205de9)
BibTeX
@misc{dccbbb47b3bb39,
  title = {Recurrence Patterns and Survival Outcomes in Clinical Stage IIB/IIC Melanoma: Can We Stratify Patients for Consideration of Neoadjuvant Immunotherapy? — Europe PMC PMID:40908447},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40908447},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cbbb47b3bb39; sha256 62e97d95d84c47c3dfa9499f60c4b3a458cd726a1acc3880d9cda715ef205de9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40908447. Agents can read the archived copy with the MCP tool read_document.